CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)

We investigated whether CD4:CD8 ratio and CD8 count were prognostic for all-cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high CD4 count. We used data from 13 European and North American cohorts of human immunodeficiency virus-infected, antiretroviral therapy (ART)-na...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Clinical infectious diseases Ročník 65; číslo 6; s. 959
Hlavní autori:	Trickey, Adam, May, Margaret T, Schommers, Philipp, Tate, Jan, Ingle, Suzanne M, Guest, Jodie L, Gill, M John, Zangerle, Robert, Saag, Mike, Reiss, Peter, Monforte, Antonella d'Arminio, Johnson, Margaret, Lima, Viviane D, Sterling, Tim R, Cavassini, Matthias, Wittkop, Linda, Costagliola, Dominique, Sterne, Jonathan A C
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 15.09.2017
Predmet:	Adolescent Adult Aged Anti-HIV Agents - therapeutic use Biomarkers - blood Cause of Death CD4-CD8 Ratio CD4-Positive T-Lymphocytes CD8-Positive T-Lymphocytes Europe - epidemiology Female HIV Infections - drug therapy HIV Infections - immunology HIV Infections - mortality Humans Lymphocyte Count Male Middle Aged North America - epidemiology Prognosis Proportional Hazards Models Viral Load Young Adult mortality HIV CD4:CD8 ratio antiretroviral therapy CD8 count
ISSN:	1537-6591, 1537-6591
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	We investigated whether CD4:CD8 ratio and CD8 count were prognostic for all-cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high CD4 count. We used data from 13 European and North American cohorts of human immunodeficiency virus-infected, antiretroviral therapy (ART)-naive adults who started ART during 1996-2010, who were followed from the date they had CD4 count ≥350 cells/μL and were virologically suppressed (baseline). We used stratified Cox models to estimate unadjusted and adjusted (for sex, people who inject drugs, ART initiation year, and baseline age, CD4 count, AIDS, duration of ART) all-cause and cause-specific mortality hazard ratios for tertiles of CD4:CD8 ratio (0-0.40, 0.41-0.64 [reference], >0.64) and CD8 count (0-760, 761-1138 [reference], >1138 cells/μL) and examined the shape of associations using cubic splines. During 276526 person-years, 1834 of 49865 patients died (249 AIDS-related; 1076 non-AIDS-defining; 509 unknown/unclassifiable deaths). There was little evidence that CD4:CD8 ratio was prognostic for all-cause mortality after adjustment for other factors: the adjusted hazard ratio (aHR) for lower vs middle tertile was 1.11 (95% confidence interval [CI], 1.00-1.25). The association of CD8 count with all-cause mortality was U-shaped: aHR for higher vs middle tertile was 1.13 (95% CI, 1.01-1.26). AIDS-related mortality declined with increasing CD4:CD8 ratio and decreasing CD8 count. There was little evidence that CD4:CD8 ratio or CD8 count was prognostic for non-AIDS mortality. In this large cohort collaboration, the magnitude of adjusted associations of CD4:CD8 ratio or CD8 count with mortality was too small for them to be useful as independent prognostic markers in virally suppressed patients on ART.
AbstractList	We investigated whether CD4:CD8 ratio and CD8 count were prognostic for all-cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high CD4 count. We used data from 13 European and North American cohorts of human immunodeficiency virus-infected, antiretroviral therapy (ART)-naive adults who started ART during 1996-2010, who were followed from the date they had CD4 count ≥350 cells/μL and were virologically suppressed (baseline). We used stratified Cox models to estimate unadjusted and adjusted (for sex, people who inject drugs, ART initiation year, and baseline age, CD4 count, AIDS, duration of ART) all-cause and cause-specific mortality hazard ratios for tertiles of CD4:CD8 ratio (0-0.40, 0.41-0.64 [reference], >0.64) and CD8 count (0-760, 761-1138 [reference], >1138 cells/μL) and examined the shape of associations using cubic splines. During 276526 person-years, 1834 of 49865 patients died (249 AIDS-related; 1076 non-AIDS-defining; 509 unknown/unclassifiable deaths). There was little evidence that CD4:CD8 ratio was prognostic for all-cause mortality after adjustment for other factors: the adjusted hazard ratio (aHR) for lower vs middle tertile was 1.11 (95% confidence interval [CI], 1.00-1.25). The association of CD8 count with all-cause mortality was U-shaped: aHR for higher vs middle tertile was 1.13 (95% CI, 1.01-1.26). AIDS-related mortality declined with increasing CD4:CD8 ratio and decreasing CD8 count. There was little evidence that CD4:CD8 ratio or CD8 count was prognostic for non-AIDS mortality. In this large cohort collaboration, the magnitude of adjusted associations of CD4:CD8 ratio or CD8 count with mortality was too small for them to be useful as independent prognostic markers in virally suppressed patients on ART. We investigated whether CD4:CD8 ratio and CD8 count were prognostic for all-cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high CD4 count.BACKGROUNDWe investigated whether CD4:CD8 ratio and CD8 count were prognostic for all-cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high CD4 count.We used data from 13 European and North American cohorts of human immunodeficiency virus-infected, antiretroviral therapy (ART)-naive adults who started ART during 1996-2010, who were followed from the date they had CD4 count ≥350 cells/μL and were virologically suppressed (baseline). We used stratified Cox models to estimate unadjusted and adjusted (for sex, people who inject drugs, ART initiation year, and baseline age, CD4 count, AIDS, duration of ART) all-cause and cause-specific mortality hazard ratios for tertiles of CD4:CD8 ratio (0-0.40, 0.41-0.64 [reference], >0.64) and CD8 count (0-760, 761-1138 [reference], >1138 cells/μL) and examined the shape of associations using cubic splines.METHODSWe used data from 13 European and North American cohorts of human immunodeficiency virus-infected, antiretroviral therapy (ART)-naive adults who started ART during 1996-2010, who were followed from the date they had CD4 count ≥350 cells/μL and were virologically suppressed (baseline). We used stratified Cox models to estimate unadjusted and adjusted (for sex, people who inject drugs, ART initiation year, and baseline age, CD4 count, AIDS, duration of ART) all-cause and cause-specific mortality hazard ratios for tertiles of CD4:CD8 ratio (0-0.40, 0.41-0.64 [reference], >0.64) and CD8 count (0-760, 761-1138 [reference], >1138 cells/μL) and examined the shape of associations using cubic splines.During 276526 person-years, 1834 of 49865 patients died (249 AIDS-related; 1076 non-AIDS-defining; 509 unknown/unclassifiable deaths). There was little evidence that CD4:CD8 ratio was prognostic for all-cause mortality after adjustment for other factors: the adjusted hazard ratio (aHR) for lower vs middle tertile was 1.11 (95% confidence interval [CI], 1.00-1.25). The association of CD8 count with all-cause mortality was U-shaped: aHR for higher vs middle tertile was 1.13 (95% CI, 1.01-1.26). AIDS-related mortality declined with increasing CD4:CD8 ratio and decreasing CD8 count. There was little evidence that CD4:CD8 ratio or CD8 count was prognostic for non-AIDS mortality.RESULTSDuring 276526 person-years, 1834 of 49865 patients died (249 AIDS-related; 1076 non-AIDS-defining; 509 unknown/unclassifiable deaths). There was little evidence that CD4:CD8 ratio was prognostic for all-cause mortality after adjustment for other factors: the adjusted hazard ratio (aHR) for lower vs middle tertile was 1.11 (95% confidence interval [CI], 1.00-1.25). The association of CD8 count with all-cause mortality was U-shaped: aHR for higher vs middle tertile was 1.13 (95% CI, 1.01-1.26). AIDS-related mortality declined with increasing CD4:CD8 ratio and decreasing CD8 count. There was little evidence that CD4:CD8 ratio or CD8 count was prognostic for non-AIDS mortality.In this large cohort collaboration, the magnitude of adjusted associations of CD4:CD8 ratio or CD8 count with mortality was too small for them to be useful as independent prognostic markers in virally suppressed patients on ART.CONCLUSIONSIn this large cohort collaboration, the magnitude of adjusted associations of CD4:CD8 ratio or CD8 count with mortality was too small for them to be useful as independent prognostic markers in virally suppressed patients on ART.
Author	Trickey, Adam Gill, M John Sterne, Jonathan A C May, Margaret T Reiss, Peter Tate, Jan Guest, Jodie L Wittkop, Linda Saag, Mike Lima, Viviane D Johnson, Margaret Ingle, Suzanne M Costagliola, Dominique Monforte, Antonella d'Arminio Zangerle, Robert Sterling, Tim R Cavassini, Matthias Schommers, Philipp
Author_xml	– sequence: 1 givenname: Adam surname: Trickey fullname: Trickey, Adam organization: School of Social and Community Medicine, University of Bristol, United Kingdom – sequence: 2 givenname: Margaret T surname: May fullname: May, Margaret T organization: School of Social and Community Medicine, University of Bristol, United Kingdom – sequence: 3 givenname: Philipp surname: Schommers fullname: Schommers, Philipp organization: Department I for Internal Medicine, University Hospital of Cologne, Germany – sequence: 4 givenname: Jan surname: Tate fullname: Tate, Jan organization: Yale University School of Medicine, West Haven, Connecticut – sequence: 5 givenname: Suzanne M surname: Ingle fullname: Ingle, Suzanne M organization: School of Social and Community Medicine, University of Bristol, United Kingdom – sequence: 6 givenname: Jodie L surname: Guest fullname: Guest, Jodie L organization: HIV Atlanta Veterans Affairs Cohort Study, Atlanta Veterans Affairs Medical Center, Decatur, Georgia – sequence: 7 givenname: M John surname: Gill fullname: Gill, M John organization: Division of Infectious Diseases, University of Calgary, Alberta, Canada – sequence: 8 givenname: Robert surname: Zangerle fullname: Zangerle, Robert organization: Innsbruck Medical University, Austria – sequence: 9 givenname: Mike surname: Saag fullname: Saag, Mike organization: Division of Infectious Disease, Department of Medicine, University of Alabama, Birmingham – sequence: 10 givenname: Peter surname: Reiss fullname: Reiss, Peter organization: Stichting HIV Monitoring, and Division of Infectious Diseases and Department of Global Health, Academic Medical Center, University of Amsterdam, and Amsterdam Institute for Global Health and Development, The Netherlands – sequence: 11 givenname: Antonella d'Arminio surname: Monforte fullname: Monforte, Antonella d'Arminio organization: Clinic of Infectious Diseases and Tropical Medicine, San Paolo Hospital, University of Milan, Italy – sequence: 12 givenname: Margaret surname: Johnson fullname: Johnson, Margaret organization: Department of HIV Medicine, Royal Free London NHS Foundation Trust, United Kingdom – sequence: 13 givenname: Viviane D surname: Lima fullname: Lima, Viviane D organization: British Columbia Centre for Excellence in HIV/AIDS, and Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, Canada – sequence: 14 givenname: Tim R surname: Sterling fullname: Sterling, Tim R organization: Vanderbilt University School of Medicine, Nashville, Tennessee – sequence: 15 givenname: Matthias surname: Cavassini fullname: Cavassini, Matthias organization: Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Switzerland – sequence: 16 givenname: Linda surname: Wittkop fullname: Wittkop, Linda organization: INSERM, Unit of Epidemiology and Biostatistics, Bordeaux – sequence: 17 givenname: Dominique surname: Costagliola fullname: Costagliola, Dominique organization: Sorbonne Universités, INSERM, UPMC Université Paris 06, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France – sequence: 18 givenname: Jonathan A C surname: Sterne fullname: Sterne, Jonathan A C organization: School of Social and Community Medicine, University of Bristol, United Kingdom
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28903507$$D View this record in MEDLINE/PubMed
BookMark	eNp1UE1P3DAUtCqq8tFe-gOqd4RDaOzYjsNtFQqsBCpC215Xjv1SDIm92E7F_kD-V7OCSr308DQzeqM3o3dI9nzwSMhnWp7Ssqm-GmfneeZSviMHVFR1IUVD9_7h--QwpYeypFSV4gPZZ6opK1HWB-SlPedn7bmCO51dAO0t7FQbJp9BJ7iN4ZcPKTsDNzo-YkzQhwg3IWY9uLwF5-FqGrWH5ThOPljsnXHozRZ-ujilYul7NBkt3M4B6HOC4GHhs4uYY_jtoh5gdY9Rb7ZnO_Kf3dzofs6cYRh0F-KurYfjxd2qaNuTj-R9r4eEn97wiPy4-LZqr4rr75fLdnFdGM5ULnrUtWS1NJ2VJe8tVVYoxq2gynDDRE1FJ3glmkZVWiLvGHaadTVapuWM7Igcv97dxPA0Ycrr0SWDcyWPYUpr2lRK8UZKNlu_vFmnbkS73kQ36rhd_309-wOSjomg
CitedBy_id	crossref_primary_10_1097_QAI_0000000000003094 crossref_primary_10_1371_journal_pone_0240880 crossref_primary_10_1016_j_ebiom_2023_104773 crossref_primary_10_12688_f1000research_19585_1 crossref_primary_10_3390_v15020322 crossref_primary_10_1186_s12889_025_24055_7 crossref_primary_10_1038_s41585_025_01078_8 crossref_primary_10_1097_QAD_0000000000001848 crossref_primary_10_1016_j_ebiom_2019_09_031 crossref_primary_10_21292_2075_1230_2020_98_5_24_31 crossref_primary_10_1038_s41392_021_00607_2 crossref_primary_10_1097_QAI_0000000000001913 crossref_primary_10_1111_hiv_13008 crossref_primary_10_1186_s12889_020_08586_9 crossref_primary_10_1097_QAD_0000000000002063 crossref_primary_10_1097_QAD_0000000000002140 crossref_primary_10_1177_0956462419834129 crossref_primary_10_1093_cid_ciad136 crossref_primary_10_1097_QAI_0000000000003121 crossref_primary_10_3389_fimmu_2024_1343124 crossref_primary_10_1097_CM9_0000000000002756 crossref_primary_10_1172_JCI142014 crossref_primary_10_1186_s12981_018_0200_4 crossref_primary_10_1093_infdis_jiab433 crossref_primary_10_1002_adbi_202300378 crossref_primary_10_1097_QAD_0000000000003801 crossref_primary_10_1097_QAD_0000000000003167 crossref_primary_10_3389_fmicb_2022_827689 crossref_primary_10_1186_s12916_018_1046_2 crossref_primary_10_1097_QAD_0000000000003171 crossref_primary_10_1007_s15010_021_01619_4 crossref_primary_10_1016_j_heliyon_2023_e22998 crossref_primary_10_1038_s41569_019_0219_9 crossref_primary_10_3390_v14112315 crossref_primary_10_1080_14787210_2021_1823217 crossref_primary_10_1016_j_jamda_2023_05_033 crossref_primary_10_1080_22221751_2025_2466695 crossref_primary_10_1016_j_jinf_2021_12_034 crossref_primary_10_3390_v15020385 crossref_primary_10_2147_IJGM_S393370 crossref_primary_10_1186_s12879_021_06991_y crossref_primary_10_3389_fmed_2025_1562537 crossref_primary_10_3389_fmicb_2022_1004960 crossref_primary_10_1080_22221751_2020_1840928 crossref_primary_10_3389_fimmu_2023_1269650 crossref_primary_10_1111_hiv_13707 crossref_primary_10_1016_j_ebiom_2022_104072 crossref_primary_10_1590_s1678_9946202466007 crossref_primary_10_1371_journal_pone_0226724 crossref_primary_10_1016_j_phrs_2023_106898 crossref_primary_10_1093_cid_ciaa1137 crossref_primary_10_3389_fimmu_2020_01541 crossref_primary_10_1093_cid_ciad671 crossref_primary_10_1002_jia2_25804 crossref_primary_10_1089_aid_2020_0182 crossref_primary_10_1093_infdis_jiaa048 crossref_primary_10_1097_MD_0000000000029252 crossref_primary_10_1016_j_biopha_2023_114427 crossref_primary_10_1002_jia2_26214 crossref_primary_10_1016_j_csbj_2021_05_021 crossref_primary_10_1016_S2352_3018_18_30004_3 crossref_primary_10_1097_QCO_0000000000000510 crossref_primary_10_1088_1751_8121_aaed5e crossref_primary_10_3390_v14092037 crossref_primary_10_1111_hiv_12800 crossref_primary_10_1016_j_cjca_2018_12_024 crossref_primary_10_1097_QAD_0000000000002891 crossref_primary_10_1111_hiv_12642 crossref_primary_10_1097_QAI_0000000000001843 crossref_primary_10_3389_fimmu_2023_1135725
ContentType	Journal Article
Contributor	Monforte, Antonella D'Arminio Justice, Amy Trickey, Adam Saag, Michael Reiss, Peter Chêne, Geneviève Vehreschild, Jorg Janne Shepherd, Leah Crane, Heidi M Del Amo, Julia Costagliola, Dominique May, Margaret Van Sighem, Ard Haerry, David Hans-Ulrich Ingle, Suzanne Miro, Jose M Williams, Matthew Sterne, Jonathan Gill, John Teira, Ramon Stephan, Christoph Sterling, Tim Guest, Jodie Smith, Colette Boulle, Andrew Dabis, François Zangerle, Robert Hogg, Robert Obel, Niels Cavassini, Matthias
Contributor_xml	– sequence: 1 givenname: Andrew surname: Boulle fullname: Boulle, Andrew – sequence: 2 givenname: Christoph surname: Stephan fullname: Stephan, Christoph – sequence: 3 givenname: Jose M surname: Miro fullname: Miro, Jose M – sequence: 4 givenname: Matthias surname: Cavassini fullname: Cavassini, Matthias – sequence: 5 givenname: Geneviève surname: Chêne fullname: Chêne, Geneviève – sequence: 6 givenname: Dominique surname: Costagliola fullname: Costagliola, Dominique – sequence: 7 givenname: François surname: Dabis fullname: Dabis, François – sequence: 8 givenname: Antonella D'Arminio surname: Monforte fullname: Monforte, Antonella D'Arminio – sequence: 9 givenname: Julia surname: Del Amo fullname: Del Amo, Julia – sequence: 10 givenname: Ard surname: Van Sighem fullname: Van Sighem, Ard – sequence: 11 givenname: Jorg Janne surname: Vehreschild fullname: Vehreschild, Jorg Janne – sequence: 12 givenname: John surname: Gill fullname: Gill, John – sequence: 13 givenname: Jodie surname: Guest fullname: Guest, Jodie – sequence: 14 givenname: David Hans-Ulrich surname: Haerry fullname: Haerry, David Hans-Ulrich – sequence: 15 givenname: Robert surname: Hogg fullname: Hogg, Robert – sequence: 16 givenname: Amy surname: Justice fullname: Justice, Amy – sequence: 17 givenname: Leah surname: Shepherd fullname: Shepherd, Leah – sequence: 18 givenname: Niels surname: Obel fullname: Obel, Niels – sequence: 19 givenname: Heidi M surname: Crane fullname: Crane, Heidi M – sequence: 20 givenname: Colette surname: Smith fullname: Smith, Colette – sequence: 21 givenname: Peter surname: Reiss fullname: Reiss, Peter – sequence: 22 givenname: Michael surname: Saag fullname: Saag, Michael – sequence: 23 givenname: Tim surname: Sterling fullname: Sterling, Tim – sequence: 24 givenname: Ramon surname: Teira fullname: Teira, Ramon – sequence: 25 givenname: Matthew surname: Williams fullname: Williams, Matthew – sequence: 26 givenname: Robert surname: Zangerle fullname: Zangerle, Robert – sequence: 27 givenname: Jonathan surname: Sterne fullname: Sterne, Jonathan – sequence: 28 givenname: Margaret surname: May fullname: May, Margaret – sequence: 29 givenname: Suzanne surname: Ingle fullname: Ingle, Suzanne – sequence: 30 givenname: Adam surname: Trickey fullname: Trickey, Adam
Copyright	The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.
Copyright_xml	– notice: The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.
CorporateAuthor	Antiretroviral Therapy Cohort Collaboration (ART-CC)
CorporateAuthor_xml	– name: Antiretroviral Therapy Cohort Collaboration (ART-CC)
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1093/cid/cix466
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1537-6591
ExternalDocumentID	28903507
Genre	Journal Article
GrantInformation_xml	– fundername: NIAAA NIH HHS grantid: U24 AA020794 – fundername: Medical Research Council grantid: G0700820 – fundername: Medical Research Council grantid: G0100221 – fundername: NIAID NIH HHS grantid: P30 AI110527 – fundername: NIAAA NIH HHS grantid: U10 AA013566 – fundername: Medical Research Council grantid: MR/J002380/1
GroupedDBID	--- ..I .2P .I3 .ZR 08P 0R~ 1KJ 1TH 29B 2AX 2WC 36B 4.4 48X 53G 5GY 5RE 5VS 5WD 6J9 70D AABZA AACGO AACZT AAJKP AAJQQ AAMVS AANCE AAOGV AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP ABBHK ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPLY ABPQP ABPTD ABQLI ABQNK ABTLG ABVGC ABWST ABXSQ ABXVV ABZBJ ACGFO ACGFS ACHIC ACPRK ACUFI ACUTJ ACUTO ACYHN ADBBV ADEYI ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADQXQ ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEUPB AEWNT AEXZC AFFZL AFIYH AFOFC AFRAH AFXAL AFYAG AGINJ AGKEF AGORE AGQXC AGSYK AGUTN AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQKUS AQVQM ATGXG AXUDD BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CDBKE CGR CS3 CUY CVF CZ4 DAKXR DCCCD DIK DILTD DU5 D~K E3Z EBS ECM EE~ EIF EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC H13 H5~ HAR HW0 HZ~ IOX IPSME J21 JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST JXSIZ KAQDR KBUDW KOP KSI KSN L7B MHKGH MJL ML0 N9A NGC NOMLY NOYVH NPM NU- NVLIB O9- OAUYM OAWHX OCZFY ODMLO ODZKP OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM PQQKQ Q1. Q5Y QBD RD5 ROX ROZ RUSNO RW1 RXO SA0 SJN TCURE TEORI TJX TMA TR2 W8F X7H YAYTL YKOAZ YXANX ~91 ~S- 7X8
ID	FETCH-LOGICAL-c428t-fea76276cbd604fd18d5824d518c4c25715b54359983a6e4b2eba2b7ed2a62b72
IEDL.DBID	7X8
ISICitedReferencesCount	75
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000408704100013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1537-6591
IngestDate	Thu Oct 02 10:06:01 EDT 2025 Thu Jul 03 03:53:02 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	6
Keywords	mortality HIV CD4:CD8 ratio antiretroviral therapy CD8 count
Language	English
License	The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c428t-fea76276cbd604fd18d5824d518c4c25715b54359983a6e4b2eba2b7ed2a62b72
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://academic.oup.com/cid/article-pdf/65/6/959/24266338/cix466.pdf
PMID	28903507
PQID	1938849662
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1938849662 pubmed_primary_28903507
PublicationCentury	2000
PublicationDate	2017-09-15
PublicationDateYYYYMMDD	2017-09-15
PublicationDate_xml	– month: 09 year: 2017 text: 2017-09-15 day: 15
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Clinical infectious diseases
PublicationTitleAlternate	Clin Infect Dis
PublicationYear	2017
References	30167571 - J Lab Precis Med. 2018 Feb;3:8. doi: 10.21037/jlpm.2018.01.10.
References_xml	– reference: 30167571 - J Lab Precis Med. 2018 Feb;3:8. doi: 10.21037/jlpm.2018.01.10.
SSID	ssj0011805
Score	2.5194635
Snippet	We investigated whether CD4:CD8 ratio and CD8 count were prognostic for all-cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	959
SubjectTerms	Adolescent Adult Aged Anti-HIV Agents - therapeutic use Biomarkers - blood Cause of Death CD4-CD8 Ratio CD4-Positive T-Lymphocytes CD8-Positive T-Lymphocytes Europe - epidemiology Female HIV Infections - drug therapy HIV Infections - immunology HIV Infections - mortality Humans Lymphocyte Count Male Middle Aged North America - epidemiology Prognosis Proportional Hazards Models Viral Load Young Adult
Title	CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)
URI	https://www.ncbi.nlm.nih.gov/pubmed/28903507 https://www.proquest.com/docview/1938849662
Volume	65
WOSCitedRecordID	wos000408704100013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaAItQLb2h5aZA4wMHq2nFipxdUpVT0sKsVKmhvKz8mYi9J2aSIP8j_YibJqhxAQuKShyIrlmY8_jyPb4R4o21ItgzMbxetNAk9rzmUWmFRI_rgcz80m7CLhVutyuXkcOumtMqdTRwMdWoj-8iPCGg4Zwic6_eX3yR3jeLo6tRC46bYywjKsFbb1XUUQbkhhZEWtZVFXqodPWmZHUUSddz8MBM74h-h5bDFnN3738ndF3cncAknozY8EDeweSjuzKfw-SPxszo1x9Wpg08sD_BNAn7juvQefAfLbct5dzQauIaHkCEQpoX5ANEJrsOmgcHrD-dcVtImZP4JLt6EL5vtVSfPh9QuTLAc6Vo7aBs4aXqyqz37LrY0u4uRx-CYH_7yjWb0lf4J1e9KCm8Je8uqevdYfD77cFF9lFMfBxnpcNPLGj2ZXFvEkIqZqZNyKXfapFy5aCLZDJWHnGAbnfwyX6AJGoPXwWLSvqC7fiJuNW2DBwK8jkVySMe0UBptk1cOZ8rVKqtnnrDXoXi9E9Ca1gkHP3yD7VW3vhbRoXg6Snl9ORJ6rDnYmhEwfvYPo5-Lfc07O3eRyF-IvZqsBL4Ut-P3ftNtXw0KSNfFcv4LEv_piA
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD4%3ACD8+Ratio+and+CD8+Count+as+Prognostic+Markers+for+Mortality+in+Human+Immunodeficiency+Virus-Infected+Patients+on+Antiretroviral+Therapy%3A+The+Antiretroviral+Therapy+Cohort+Collaboration+%28ART-CC%29&rft.jtitle=Clinical+infectious+diseases&rft.au=Trickey%2C+Adam&rft.au=May%2C+Margaret+T&rft.au=Schommers%2C+Philipp&rft.au=Tate%2C+Jan&rft.date=2017-09-15&rft.eissn=1537-6591&rft.volume=65&rft.issue=6&rft.spage=959&rft_id=info:doi/10.1093%2Fcid%2Fcix466&rft_id=info%3Apmid%2F28903507&rft_id=info%3Apmid%2F28903507&rft.externalDocID=28903507
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1537-6591&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1537-6591&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1537-6591&client=summon